CIK: 0001388551 · Show all filings
Period: Q4 2013 (← Previous) (Next →)
Filing Date: Feb 14, 2014
Total Value ($000): $157,477 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SYNTA PHARMACEUTICALS CORP | 28,641,849 | $150,057 | 95.3% | $7.92 | — | COM | 87162T206 |
| — | CELATOR PHARMACEUTICALS INC | 2,246,469 | $7,301 | 4.6% | $3.25 | — | COM | 15089R102 |
| — | HALLMARK FINL SVCS INC EC | 13,445 | $119 | 0.1% | $9.39 | — | COM NEW | 40624Q203 |